XORTX THERAPEUTICS INC.

Profile

Company Names

XORTX THERAPEUTICS INC.

Addresses

3710 - 33RD STREET NW, CALGARY, A0 T2L 2M1

SUITE 2400 - 745 THURLOW STREET, VANCOUVER, A1 V6E 0C5

Phone Numbers

403-455-7727
403-607-2621

 

Entity Type:

CORPORATION

Industry:

OTHER

Year Incorporated:

> 5 years ago

State Incorporated:

BRITISH COLUMBIA, CANADA

Total Amount Raised:

$505,283.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2024-10-18 
$0.00 
$1,767,566.00 
$1,767,566.00 
Equity 
1
2018-01-10 
$505,283.00 
$505,283.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ALLEN 
 
DAVIDOFF 
EXECUTIVE OFFICER, DIRECTOR
XORTX THERAPEUTICS INC.
STACY 
 
EVANS 
EXECUTIVE OFFICER
XORTX THERAPEUTICS INC.
JAMES 
 
FAIRBAIRN 
EXECUTIVE OFFICER
TRELAWNEY MINING + EXPLORATION INC.   |  CGX ENERGY INC.   |  JBI, INC.   |  SATORI RESOURCES INC.   |  MAINSTREAM MINERALS CORP   |  XORTX THERAPEUTICS INC.
WILLIAM 
 
FARLEY 
DIRECTOR
CASABLANCA MINING LTD.   |  LUSTROS INC.   |  PONO LIFE SCIENCES, LLC   |  XORTX THERAPEUTICS INC.
ANTHONY 
J. 
GIOVINAZZO 
DIRECTOR
TITAN MEDICAL INC   |  KALGENE PHAMACEUTICALS INC.   |  KALGENE INC.   |  XORTX THERAPEUTICS INC.
STEPHEN 
 
HAWORTH 
EXECUTIVE OFFICER
XORTX THERAPEUTICS INC.
ABIGAIL 
 
JENKINS 
DIRECTOR
XORTX THERAPEUTICS INC.
JOHN 
 
MEEKISON 
EXECUTIVE OFFICER
NATCORE TECHNOLOGY INC.   |  XORTX THERAPEUTICS INC.   |  EXRO TECHNOLOGIES INC.   |  TELO GENOMICS CORP.   |  EVOLVE CHARGING CORP.
ALAN 
 
MOORE 
DIRECTOR
PACGEN BIOPHARMACEUTICALS CORP   |  INCAPTURE TECHNOLOGIES LLC   |  XORTX THERAPEUTICS INC.   |  BYTE TO BITE INDUSTRIES, INC.
RAYMOND 
 
PRATT 
DIRECTOR
XORTX THERAPEUTICS INC.
BRUCE 
 
ROWLANDS 
DIRECTOR
XORTX THERAPEUTICS INC.
PATRICK 
 
TREANOR 
DIRECTOR
XORTX THERAPEUTICS INC.
PAUL 
 
VAN DAMME 
DIRECTOR
QUEST PHARMATECH INC.   |  ONCOQUEST INC.   |  BRADMER PHARMACEUTICALS INC   |  XORTX THERAPEUTICS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-10-31
D
Link
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-10-18 
2018-01-25
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2018-01-10 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
A.G.P./ALLIANCE GLOBAL PARTNERS
8361